Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03072459 · ClinicalTrials.gov registry record

A Retrospective Study of the Navio Robotic-assisted Surgical System

A clinical trial, sponsored by Smith & Nephew.

Completed
Registry status
128
Enrollment target

NCT03072459: Completed study, sponsored by Smith & Nephew.

NCT03072459 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 128 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03072459 has completed, sponsored by Smith & Nephew.

COMPLETED
Registry status
128 participants
Enrollment target

Study Summary

A retrospective, multi-center, cohort study with prospective follow-up and comparison to historical control

Primary Outcome

Analysis of the absence of device revision (overall survivorship) outcomes assessed from Baseline through 120 weeks post-surgical implantation.

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2017-07-10
Est. Completion 2017-11-29
Smith & Nephew

72 total trials

What the finished NCT03072459 record still lists

NCT03072459 is an observational study that tracks outcomes without assigning an intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT03072459 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03072459 about?

NCT03072459 is a clinical study titled "A Retrospective Study of the Navio Robotic-assisted Surgical System". A retrospective, multi-center, cohort study with prospective follow-up and comparison to historical control

What is the current status of trial NCT03072459?

This trial is currently completed. The enrollment target is 128 participants. The study started on 2017-07-10. Estimated completion is 2017-11-29.

Who is sponsoring clinical trial NCT03072459?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03072459, the US trial registry maintained by the National Library of Medicine. NCT03072459 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.